Transforming HIV Care: UT+ Diagnostics' Innovative 4th Gen HIV Test Approved by Medical Device Authority, Ministry of Health (Malaysia).
Kuala Lumpur, Malaysia –20 May 2025 – Universal Therapeutics Diagnostics Sdn Bhd, a leader in innovative medical diagnostic solutions is pleased to announce a significant research breakthrough with the successful approval of the “UT+ Diagnostics 4th Generation HIV 1/2 + p24 Test” by Medical Device Authority (MDA), Ministry of Health Malaysia.
Universal Therapeutics Diagnostics Awarded Exclusive Supply Contract with Ministry of Health Malaysia for Syphilis Rapid Test Cassettes
New Agreement Ensures Improved National Syphilis Testing Capacity from 2025 to 2027
Universal Therapeutics Diagnostics, a subsidiary of Universal Therapeutics Group Sdn Bhd is proud to announce that it has been awarded an exclusive supply contract by the Ministry of Health Malaysia (MOH) for its UT + DIAGNOSTICS Syphilis Rapid Test Cassette. Commencing in 2025 and spanning two years, this agreement involves the provision of two million test cassettes to MOH facilities and partner organisations throughout Malaysia.
Watsons has launched two of our health products: the AwarerHOME™ HIV Oral Self Test kit and the Que Sarah, Sarah 1 Step Pregnancy Test kit
Watsons Malaysia has launched two of our health products designed to empower individuals in managing their health: the AwarerHOME™ HIV Oral Self Test kit and the Que Sarah, Sarah 1 Step Pregnancy Test kit.
Clarification Statement- UT + Diagnostics Covid-19 Antigen Detection Kit (2-in-1 Saliva/Nasal Swab)
Dear Valued Distributors,
UT + Diagnostics Covid-19 Antigen Detection Kit (2-in-1 Saliva/Nasal Swab)
1. Universal Therapeutics wishes to clarify that our proprietary devices branded under “Universal Therapeutics Diagnostics” is proudly manufactured and assembled in Malaysia (Made in Malaysia).
Universal Therapeutics Diagnostics and Community Healthcare Clinic (CHC Clinic) Collaborate to Provide High-Accuracy AwarerPRO™ HIV 1/2 Rapid Test (Oral Fluid)
Kuala Lumpur, Malaysia, 17 October 2023- Universal Therapeutics Diagnostics is excited to announce its strategic partnership with Community Healthcare Clinic, a trusted leader in HIV and STD screening services. This collaboration introduces the highly accurate and reliable AwarerPRO™ HIV 1/2 Rapid Test (Oral Fluid), clinically assessed to have an accuracy of 99.61%, a sensitivity of 99.23%, and a specificity of 100%.
Universal Therapeutics Diagnostics and The Red Clinic Collaborate to Provide High-Accuracy AwarerPRO™ HIV 1/2 Rapid Test (Oral Fluid)
Kuala Lumpur, Malaysia, 15 September 2023 - Universal Therapeutics Diagnostics proudly announces its strategic partnership with The Red Clinic, a respected leader in HIV Screening. This collaboration introduces the cutting-edge AwarerPRO™ HIV 1/2 Rapid Test (Oral Fluid) with an impressive accuracy of 99.61%, sensitivity of 99.23%, and specificity of 100%.
Universal Therapeutics Diagnostics Launches “Que Sarah, Sarah”- 1 Step Pregnancy Test Cassette and Test Pen
Kuala Lumpur, Malaysia, 3 July 2023 – Universal Therapeutics Diagnostics, a leading medical device manufacturer based in Malaysia, is proud to announce the release of two pregnancy test kits. The Que Sarah, Sarah 1 Step Pregnancy Test Cassette and Que Sarah, Sarah 1 Step Pregnancy Test Pen have been meticulously designed to provide accurate and reliable results, offering women a convenient and effective means of early pregnancy detection in the comfort of their own homes.
Universal Therapeutics Launches Groundbreaking AwarerPRO™ HIV 1/2 Rapid Test (Oral Fluid)
Kuala Lumpur, Malaysia, 19 June 2023 - Universal Therapeutics, a leading healthcare company dedicated to advancing medical solutions, is excited to announce the successful registration of the AwarerPRO™ 1/2 HIV Rapid Test Kit (Oral Fluid). This innovative test kit, with an impressive 99.61% accuracy rate independently verified by third parties, is poised to revolutionise HIV testing and significantly impact the healthcare industry.
Bringing Joy to Local Community with Back to School Program
Kuala Lumpur, Malaysia - On January 7th, 2023, Universal Therapeutics and its subsidiary UT Pharmacy had the honor of partnering with Selangor State Assemblywoman YB Puan Michelle Ng to present 400 bursaries to young students as part of their Back to School program. The program was launched with the aim of fostering a love for education and promoting progress in the community.
Universal Therapeutics Diagnostics Sdn Bhd receives formal approval from Medical Device Authority (MDA), Malaysia our in-house manufacturing licence
Kuala Lumpur, Malaysia, 1 November 2022- Universal Therapeutics Diagnostics Sdn Bhd (“UTD”) receives the official nod from its competent and governing authority Medical Device Authority (MDA, Ministry of Health), Malaysia to commence her In- Vitro Diagnostics (“IVD”) production in its own facility.
Proudly “In-house” and “Made in Malaysia”, the plant boasts a menu of IVDs for medical practitioners and home users. UTD’s current focus will be pregnancy, infectious diseases, drug, dengue, and malaria IVDs.
Universal Therapeutics partners DoctorOnCall for strategic distribution and administration of COVID-19 self-test kits in Malaysia
Kuala Lumpur, Malaysia, 12 October 2021-- Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced its partnership with DoctorOnCall, Malaysia’s first and largest digital health platform. Consumers can now visit DoctorOnCall’s website and purchase COVID-19 self-test kits at a transparent, fixed price, and have the kits delivered to their homes.
Medical Device Authority approves TIB SARS-CoV-2 Antigen Rapid Test Kit (Saliva) for Self-Test in Malaysia
Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced that the Medical Device Authority of Malaysia (MDA) has approved the SARS-CoV-2 Antigen Rapid Test Kit (Saliva) for self-testing.
Manufactured by Triplex International Biosciences (China), the easy-to-use Rapid Test Kit can quickly detect the possibility of a COVID-19 infection, with a sensitivity of 100% specificity of 100% and accuracy of 100%.
Corporate Misrepresentations
IMPORTANT ADVISORY:
It has come to the attention of Universal Therapeutics that there have been fake brochures, presentations, certificates, and documents ("materials") bearing our company name circulating in forums, social media, and the physical marketplace.
Please ensure the authenticity of the documents by verifying these materials directly with us through legal@universal-therapeutics.com or call our office.
Medical Device Authority (MDA)
Medical Device Authority (MDA) Malaysia Approves and Recommends
Hotgen Novel Coronavirus 2019-nCoVAntigen Test Colloidal Gold) Rapid Test Kit.
Universal Therapeutics Sdn. Bhd. is pleased to announce that the Hotgen Novel Coronavirus 2019-nCoVAntigen Test (Colloidal Gold) (“Hotgen Antigen Test”) has been approved and recommended for use by the Medical Device Authority of the Malaysia Ministry of Health (“MDA”).
Bin Suhail International
Bin Suhail International to distribute Covid-19 tests. Abu Dhabi company to market test kits in UAE, Oman, and Saudi Arabia.
Bin Suhail International (Abu Dhabi) has been chosen by Universal Therapeutics Ltd. of Kuala Lumpur as sole distributor in United Arab Emirates, Oman, and Saudi Arabia for its licensed Beijing HotGen Biotech RNA PCR COVID-19 Nucleic Acid, and Beijing HotGen Biotech Novel Coronavirus 2019-nCoV Antigen Test (Colloidal Gold) test kits.
RT-PCR Technique
Universal Therapeutics to offer second Covid-19 test. This test is based on a one-step highly accurate RT-PCR technique.
A second, more comprehensive test for the detection of Covid-19 is available to health care providers in Singapore, Malaysia, Thailand, United Arab Emirates, Kenya, and Ghana. Beijing Hotgen Biotech Co., Ltd. has announced the appointment of Universal Therapeutics as Main Distributor for their RT- PCR COVID-19 Nucleic Acid Test Kit (PCR-Fluorescent Probe Method).